Skip to content

    Recently Viewed

      Listening...

      lede-What You Need to Know About Johnson & Johnson's 2020 Second-Quarter Earnings.jpg

      What you need to know about Johnson & Johnson’s 2020 second-quarter earnings

      Check out this infographic breakdown of the company’s second-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.

      Share Article
      share to
      Inset - Quarterly Earnings Ribbon

      This morning, Johnson & Johnson shared its second-quarter performance.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “The resilience of our diversified business has enabled us to continue delivering value to our stakeholders, even in the face of the COVID-19 global pandemic,” says Joseph Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson. “This sustainability, coupled with Johnson & Johnson’s rich history of being at the forefront of scientific innovation, public health and global community impact, reinforces our long-term business outlook, and motivates our colleagues and partners to responsibly develop and provide a safe, effective and affordable vaccine to people around the world as soon as possible.”

      For more details about the company’s 2020 second-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


      Q2 2020 Johnson & Johnson Earnings infographic

      Johnson & Johnson’s 2020 2nd-Quarter Earnings

      Read the earnings press release, which includes full financial details for the second quarter of 2020.

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      Health & wellness
       Blue latex gloved hand pointing at a brain MRI scan to pinpoint brain circuits associated with depression symptoms

      Is this the end of one-size-fits-all treatments for depression?

      Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.